相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
Soley Bayraktar et al.
CANCER (2012)
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
Xin-Sheng Deng et al.
CELL CYCLE (2012)
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
S. Bo et al.
DIABETES OBESITY & METABOLISM (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Sirwan Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Prognostic Influence of Metformin as First-Line Chemotherapy for Advanced Nonsmall Cell Lung Cancer in Patients With Type 2 Diabetes
Ben-Xu Tan et al.
CANCER (2011)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
Laurent Azoulay et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of ErbB2/IGF-1 receptor interactions
Bolin Liu et al.
CELL CYCLE (2011)
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Matteo Monami et al.
DIABETES CARE (2011)
Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
S. C. Larsson et al.
DIABETOLOGIA (2011)
Use of metformin and the risk of ovarian cancer: A case-control analysis
Michael Bodmer et al.
GYNECOLOGIC ONCOLOGY (2011)
Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer
Kirsten Erickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study
Melinda L. Irwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Catherine Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metabolic profile, physical activity, and mortality in breast cancer patients
Aina Emaus et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Kunihiro Hosono et al.
CANCER PREVENTION RESEARCH (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Vuk Stambolic et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2009)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
Jocelyn S. Kasper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Reduced Antidiabetic Effect of Metformin and Down-regulation of Hepatic Oct1 in Rats with Ethynylestradiol-Induced Cholestasis
Hyo-Eon Jin et al.
PHARMACEUTICAL RESEARCH (2009)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
Metformin suppresses intestinal polyp growth in ApcMin/+ mice
Ayako Tomimoto et al.
CANCER SCIENCE (2008)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia A nested case-control analysis
Michael Bodmer et al.
DIABETES CARE (2008)
Diabetes and Risk of Non-Hodgkin's Lymphoma A meta-analysis of observational studies
Joanna Mitri et al.
DIABETES CARE (2008)
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2008)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Anna Marie Mulligan et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
Gizeh Perez-Tenorio et al.
CLINICAL CANCER RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Metabolic syndrome as a prognostic factor for breast cancer recurrences
Patrizia Pasanisi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer
M Liu et al.
CANCER RESEARCH (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
PI3K/Akt/mTOR pathway as a target for cancer therapy
D Morgensztern et al.
ANTI-CANCER DRUGS (2005)
Thiazolidinediones, like metformin, inhibit respiratory complex I -: A common mechanism contributing to their antidiabetic actions?
B Brunmair et al.
DIABETES (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
The biology and clinical relevance of the PTEN tumor suppressor pathway
I Sansal et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
DH Yu et al.
ONCOGENE (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
